Ascendis Pharma A/S (ASND) |
| 241.71 -8.13 (-3.25%) 04-15 16:00 |
| Open: | 249.84 |
| High: | 250.08 |
| Low: | 241.03 |
| Volume: | 645,095 |
| Market Cap: | 14,836(M) |
| PE Ratio: | -54.93 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 292.86 |
| Resistance 1: | 250.74 |
| Pivot price: | 230.97 |
| Support 1: | 227.17 |
| Support 2: | 212.60 |
| 52w High: | 250.74 |
| 52w Low: | 150.89 |
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Financials
| EPS | -4.340 |
| Book Value | -3.060 |
| PEG Ratio | 0.00 |
| Gross Profit | 10.184 |
| Profit Margin (%) | -31.67 |
| Operating Margin (%) | 0.96 |
| Return on Assets (ttm) | -6.9 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 16 Apr 2026
Ascendis Pharma Issues New Employee Warrants as Part of Long-Term Incentive Program - TipRanks
Wed, 15 Apr 2026
Ascendis Pharma (ASND) to list ordinary shares directly on Nasdaq - MSN
Wed, 15 Apr 2026
Employee warrant grants at Ascendis Pharma (NASDAQ: ASND) - Stock Titan
Wed, 15 Apr 2026
Ascendis Pharma A/S (ASND) reports positive week 52 data from phase 2 new InsiGHTS trial - MSN
Mon, 13 Apr 2026
Ascendis Pharma A/S (NASDAQ:ASND) Hits New 52-Week High - Here's What Happened - MarketBeat
Sun, 12 Apr 2026
How Investors May Respond To Ascendis Pharma (ASND) Achondroplasia Combo Data And YUVIWEL Launch - Sahm
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
